Filing Details

Accession Number:
0001372514-24-000063
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-14 15:40:23
Reporting Period:
2024-06-14
Accepted Time:
2024-06-14 15:40:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1372514 Kiora Pharmaceuticals Inc KPRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1892943 Joseph Eric Daniels C/O Kiora Pharmaceuticals, Inc.
332 Encinitas Blvd., Suite 102
Encinitas CA 92024
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-14 1,431 $5.29 11,222 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct